Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Clinics ; 67(8): 923-929, Aug. 2012. ilus, graf, tab
Article Dans Anglais | LILACS | ID: lil-647797

Résumé

OBJECTIVE: Ischemic preconditioning and some drugs can protect tissues from injury by preserving microcirculation. This study evaluated vascular permeability in a hamster cheek pouch preparation using either short ischemic periods or bradykinin as preconditioning stimuli followed by 30 min of ischemia/reperfusion. METHOD: Sixty-six male hamsters were divided into 11 groups: five combinations of different ischemic frequencies and durations (one, three or five shorts periods of ischemia, separated by one or five minutes) with 10 min intervals between the ischemic periods, followed by 30 min ischemia/reperfusion; three or five 1 min ischemic periods with 10 min intervals between them followed by the topical application of histamine (2 µM); bradykinin (400 nM) followed by 30 min of ischemia/reperfusion; and three control groups (30 min of ischemia/reperfusion or histamine or bradykinin by themselves). Macromolecular permeability was assessed by injection of fluorescein-labeled dextran (FITC-dextran, MW= 150 kDa; 250 mg/Kg body weight), and the number of leaks/cm2 was counted using an intravital microscope and fluorescent light in the cheek pouch. RESULTS: Plasma leakage (number of leaks/cm²) was significantly reduced by preconditioning with three and five 1 min ischemic periods, one and three 5 min ischemic periods and by bradykinin. Histamine-induced macromolecular permeability was also reduced after three periods of 5 min of ischemia. CONCLUSION: Short ischemic periods and bradykinin can function as preconditioning stimuli of the ischemia/reperfusion response in the hamster cheek pouch microcirculation. Short ischemic periods also reduced histamineinduced macromolecular permeability.


Sujets)
Animaux , Cricetinae , Mâle , Perméabilité capillaire/effets des médicaments et des substances chimiques , Préconditionnement ischémique/méthodes , Lésion d'ischémie-reperfusion/traitement médicamenteux , Bradykinine/pharmacologie , Joue/vascularisation , Modèles animaux de maladie humaine , Agonistes histaminergiques/pharmacologie , Histamine/pharmacologie , Microcirculation , Plasma sanguin/effets des médicaments et des substances chimiques , Plasma sanguin/physiologie , Lésion d'ischémie-reperfusion/sang , Facteurs temps , Résultat thérapeutique , Vasodilatateurs/pharmacologie
SÉLECTION CITATIONS
Détails de la recherche